At the Forefront of Cancer Research

catholic health roswell park logo

Catholic Health is pushing the boundaries in cancer treatment. Our affiliation with Roswell Park, one of the nation’s leading cancer research centers, gives Long Islanders exclusive access to the newest and most innovative treatments available only through clinical trials.

Our partnership with Roswell Park brings together physicians, hospitals and care teams across New York State to create a community-based care network focused on improving cancer care. St. Francis Hospital & Heart Center® and Good Samaritan Hospital are also members of the Alliance for Clinical Trials in Oncology.

The Future of Cancer Therapy

Clinical trials play an essential role in the fight against cancer. They are the only scientific way to prove a new treatment works better than the current standard of care. Some clinical trials test a drug, a medical device or a new way of doing surgery. Other trials test new ways to prevent disease, diagnose cancer or improve quality of life.

Roswell Park provides helpful resources to learn more about clinical trials:

Talk with your Catholic Health oncologist to decide if a clinical trial is right for you.

Learn more about Roswell Park

Current Open Clinical Trials

CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy

T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial

A Phase II Trial of Sacituzumab Govitecan for Patients with HER2-Negative Breast Cancer and Brain Metastases

View breast cancer services

NHLBI-MDS National Myelodysplastic Syndrome (MDS) study (registry)

Myelofibrosis: Phase 3 Study of Navitoclax Plus Ruxolitinib Versus Best Available Therapy in Subjects with Relapsed/Refractory Myelofibrosis (TRANSFORM-2)                                                                        

The Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease Registry

  • Principal Investigator: Dr. Dilip Patel

View leukemia and blood cancers services

A phase I/II Basket Trial of the EGF Vaccine CIMAvax in combination with the Anti-PD1 therapy in patients with advanced non-small cell lung cancer or squamous head and neck cancer.

A phase I/II Basket Trial of the EGF Vaccine CIMAvax in combination with the Anti-PD1 therapy in patients with advanced non-small cell lung cancer or squamous head and neck cancer.

Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)

 
A Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously-Treated Non-Small Cell Lung Cancer (Lung-Map Screening Study)

Randomized Phase III Study of Combination AZD9291 (osimertinib) and Bevacizumab versus AZD9291 (osimertinib) Alone as First-Line Treatment for Patients with Metastatic EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)

A Randomized Phase III Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Observation for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein

A Phase II Study of AMG510 in participants with previously treated Stage IV or Recurrent KRAS G12C Mutated Non-Squamous Non-Small Cell Lung Cancer (Lung-MAP sub-study)

Integration of Immunotherapy into adjuvant therapy for resected NCLC: ALCHEMIST CHEMO-IO (ACCIO)

S1800D, A Phase II/III Study of N-803 (ALT-803) plus Pembrolizumab versus Standard of Care in Participants with Stage IV or Recurrent Non-Small Cell Lung Cancer Previously Treated with Anti-PD-1 or Anti-PD-L1 Therapy (Lung-MAP Non-Match Sub-Study)

S1914 A Randomized Phase III Trial of Induction/Consolidation Atezolizumab + SBRT versus SBRT Alone in High Risk, Early Stage NCSLC

View lung cancer services

ASTEROID- Assessing Single-Fraction SBRT versus Standard Palliative Radiation in Patients with Metastatic Disease

Effective Quadruplet Utilization After Treatment Evaluation (EQUATE): A Randomized Phase 3 Trial for Newly Diagnosed Multiple Myeloma Not Intended For Early Autologous Transplantation                                                                                                                                               

S1806 Phase III Randomized Trial of Concurrent Chemoradiotherapy with or without Atezolizumab in Localized Muscle Invasive Bladder Cancer

St. Francis Hospital Cardio-Oncology Registry 

  • Principal Investigator: Dr. Haoyi Zheng

Riding for a Cure

Catholic Health, the Town of Oyster Bay, and Ride for Roswell recently teamed up for Empire State Ride Long Island to raise critical funds to advance cancer research.
 

Zita Murano, a Catholic Health cancer patient who is enrolled in a clinical trial at the Cancer Institute at Good Samaritan Hospital, joined the ride. Zita was diagnosed with stage 4 lung cancer and nine brain tumors. The clinical trial, combined with a treatment plan overseen by oncologists at the Cancer Institute, eliminated the brain tumors and shrunk the lung cancer tumor by 40 percent. 

“It’s taken me a while to come to terms with the fact that I’m not going to be cancer free. But without the care I’ve received to this point, the outcome might have been much different,” said Zita.

Read more about Zita's story

Request More Information About Clinical Trials

Full Name
Preferred Method of Contact

Clinical Excellence. Compassionate Care.

Cancer Services

Diagnosis and treatment for all types and stages of cancer.

Catholic Health Cancer Care Team

Board-certified oncologists and a supporting team of cancer specialists.

Catholic Health Cancer Institutes

Comprehensive cancer services at locations across Long Island.